Neuromuscular Electrical Stimulation in Foot and Ankle Surgery
Launched by NYU LANGONE HEALTH · Apr 12, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of a treatment called Neuromuscular Electrical Stimulation (NMES) on patients who have undergone surgery for ankle fractures. The goal is to see if using this treatment five days a week for ten weeks after surgery can help improve muscle strength in the calf, specifically the gastrocnemius muscle. Participants will also take part in standard physical therapy starting six weeks after their surgery. The trial will measure not only the strength of the muscle but also how well patients can perform everyday activities like standing up, walking, and climbing stairs.
To be eligible for this trial, participants need to be between the ages of 18 and 75 and must be able to give their consent to join. They must also be scheduled for surgery to repair an ankle fracture. However, individuals with certain medical conditions, such as rheumatoid arthritis, neurological disorders, or those who have recently had other surgeries, will not be able to participate. If you join the trial, you'll be part of a study that aims to improve recovery after ankle surgery, and your progress will be closely monitored through various strength and functional tests.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Capable and willing to provide informed consent
- • Undergoing a procedure that involves repairing an ankle fracture.
- Exclusion Criteria:
- Patients with medical histories that include:
- • Rheumatoid arthritis
- • Connective tissue disorders
- • Chronic corticosteroid use
- • Implanted electrical devices
- • Neurological disorders
- • Non-ambulatory status
- • Recent surgery (within the last 3 months) that is not related to the study
- • Scheduled to undergo surgery in the near future
- • Epilepsy
- • Diagnosed with cancer
- • Have suffered acute trauma or recently have had a surgical procedure (not related to the study)
- • Have cardiac problems or cardiac disease
- • Have an abdominal hernia
- • Have venous thrombosis
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Raymond J. Walls, MD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported